Nihon Kohden (OTCMKTS:NHNKY) Shares Gap Down – Here’s Why

Nihon Kohden Corporation (OTCMKTS:NHNKY)’s share price gapped down before the market opened on Tuesday . The stock had previously closed at $9.4825, but opened at $8.8675. Nihon Kohden shares last traded at $8.8925, with a volume of 1,436 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Zacks Research upgraded Nihon Kohden to a “hold” rating in a research note on Monday, April 27th. One investment analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Buy”.

Nihon Kohden Trading Down 6.5%

The firm has a market capitalization of $1.52 billion, a price-to-earnings ratio of 15.03 and a beta of 0.41. The company has a 50-day moving average of $9.41 and a 200-day moving average of $10.39.

Nihon Kohden (OTCMKTS:NHNKY) last posted its quarterly earnings results on Thursday, May 14th. The company reported $0.34 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.24 by $0.10. The business had revenue of $453.10 million for the quarter, compared to analyst estimates of $414.40 million. Nihon Kohden had a return on equity of 9.48% and a net margin of 6.08%. On average, research analysts forecast that Nihon Kohden Corporation will post 0.61 earnings per share for the current year.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.